Dr. Barney J. Stern is a neurologist specializing in vascular neurology and neurological complications of sarcoidosis. His work in vascular neurology has covered all aspects of stroke management, including prevention and acute, subacute and chronic care. Dr. Stern also provides complex care management for patients suffering from neurosarcoidosis. His research focuses on understanding the biology and clinical outcomes of neurovascular disease and neurological complications associated with sarcoidosis. Dr. Stern has served as the medical safety monitor on a number of National Institutes of Health (NIH) stroke studies. In his new role at Johns Hopkins, Dr. Stern will be seeing outpatients as a member of the Advanced Clinical Neurology division with Dr. John Probasco. Dr. Stern is rated as an Elite provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Neurosarcoidosis, Stroke, Herpes Zoster Oticus, Arachnoiditis, and Thrombectomy.

Dr. Pardo's interest in transverse myelitis centers on management of acute myelitis, biomarkers of the disease in cerebrospinal fluid (CSF) and blood, and the role of neuroimmune factors in the pathogenesis of myelopathies. Along with others neurologists and health care providers in the Johns Hopkins Transverse Myelitis Center, Dr. Pardo focuses on a comprehensive approach in the diagnosis and management of myelopathies, myelitis, neuroimmunological and neuroinfectious disorders. Dr. Pardo is rated as an Elite provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Acute Flaccid Myelitis (AFM), Neurosarcoidosis, Transverse Myelitis, Zika Virus Disease, and Gastrostomy.

Dr. Chen practices Pulmonary and Critical Care Medicine. His primary area of interest is sarcoidosis, and he has extensive experience in the diagnosis and treatment of sarcoidosis in all of its forms, and the management of consequences of this systemic disease. The Sarcoidosis Clinic often serves to coordinate management of patients with multi-organ involvement with sarcoidosis, and to this end Dr. Chen actively maintains clinical and research collaborations with Cardiology, Cardiovascular Nuclear Medicine, Neurology, and Ophthalmology. Additionally, Dr. Chen participates as a Physician Champion in the Johns Hopkins Health System Epic project to improve the safety and quality of care of critically ill patients through optimization of the electronic medical record. His work involves developing systems-based approaches to complex management issues, including sepsis and severe alcohol withdrawal. Dr. Chen is rated as a Distinguished provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Sarcoidosis, Neurosarcoidosis, Lung Metastases, and Acute Interstitial Pneumonia.

Dr. Wise is a pulmonary, critical care physician. He is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. He is a consultant for patients with scleroderma and interstitial lung disease. He has expertise in pulmonary physiology and lung function testing. Dr. Wise’s research focus is the conduct of multi-center clinical trials in airway diseases and related translational research. Dr. Wise is the co-director of the Pulmonary T32 Multi-disciplinary Training Program in Pulmonary Disease. Dr. Wise is rated as a Distinguished provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Systemic Sclerosis (SSc), Interstitial Lung Disease, Acute Interstitial Pneumonia, and Sarcoidosis.

Dr. Michelle Sharp practices Pulmonary and Critical Care Medicine. Her primary area of interest is sarcoidosis, and she has experience in the diagnosis and treatment of sarcoidosis in all of its forms, and the management of consequences of this systemic disease. The Johns Hopkins Sarcoidosis Clinic serves to coordinate management of patients with multi-organ involvement with sarcoidosis, and to this end Dr. Sharp maintains clinical and research collaborations with Cardiology, Neurology, and Ophthalmology. Dr. Sharp received her B.S. from Tulane University. She earned her M.D. from the Louisiana State University School of Medicine. She completed her residency and fellowship in pulmonary and critical care medicine at Johns Hopkins. Dr. Sharp is rated as a Distinguished provider by MediFind in the treatment of Neurosarcoidosis. Her top areas of expertise are Neurosarcoidosis, Sarcoidosis, Necrotizing Granuloma, and Lung Metastases.

Matthew Lammi, MD MSCR is an Associate Professor of Medicine and part of the Interstitial Lung Disease (ILD) Program. Dr. Lammi obtained his medical degree from Temple University School of Medicine and did his internal medicine, pulmonary, and critical care training at Temple University Hospital. He then joined the faculty at LSU in New Orleans, where he served as the Director of the Comprehensive Pulmonary Hypertension Center. He joined Johns Hopkins in 2023. He currently serves as the Associate Director of the Johns Hopkins Pulmonary Fibrosis Foundation Care Center and is the Associate Program Director for the Advanced Lung Disease Fellowship. His research focuses on the intersection between ILD and pulmonary hypertension, particularly in patients with systemic sclerosis. He is currently a co-Principal Investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is active in numerous societies and serves as the Chair of the Research Committee for the Pulmonary Hypertension Association. Dr. Lammi is rated as an Advanced provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Pulmonary Hypertension, Sarcoidosis, Systemic Sclerosis (SSc), Interstitial Lung Disease, and Lung Transplant.

Nancy Lin is a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Lin is rated as an Advanced provider by MediFind in the treatment of Neurosarcoidosis. Her top areas of expertise are Sarcoidosis, Neurosarcoidosis, Beryllium Disease, and Interstitial Lung Disease.

Dr. Howard Steiner is an instructor of medicine at the Johns Hopkins School of Medicine. He has been practicing pulmonary and sleep consultative medicine since 1989. In his role as a diagnostician, he guides the evaluation and management of respiratory problems including infectious, malignant, allergic, autoimmune, and sleep-related disorders. He has been part-time faculty in the Johns Hopkins Pulmonary Division since 1991, is a Fellow in the American College of Chest Physicians, and mentors medical students, residents, and pulmonary fellows training at the Johns Hopkins Hospital. Contact for Research Inquiries 10755 Falls Road Pavilion I, Suite 200 Lutherville, MD 21093 Phone: (410) 583-7124 Selected Publications Lwebuga-Mukasa JS, Steiner H. Monoclonal antibody to rat lung Maclura Pomifera agglutinin (MPA) lectin binding glycoprotein localizes apically on rat and human type II pneumocytes and Clara cells. J Cell Biol 107:71a, 1989. Roberts PJ, McBean GJ, Steiner H, Kohler C, Schwarcz R. Lesioning Effects of Ibotenate in the immature rat brain and protection by 2-amino-7 phosphonoheptanoic acid. Soc Neurosci Abst 9:261, 1983. Steiner H, Ingbar DI. Mechanisms of lung injury and repair. In: Matthay RA, Matthay MA, Wiedemann HP eds. Annual Review of Pulmonary and Critical Care Medicine. Hanley & Belfus (Philadelphia, 1989), pp 205-223. Steiner H, Lwebuga-Mukasa JS. A549 cells display distinct functional and morphologic properties depending on their culture substratum. J Cell Biol 107:71a, 1989. Steiner H, Lwebuga-Mukasa JS. A549 cells produce a factor which is Mitogenic for human lung fibroblasts. Amer Rev Resp Dis 139:A492 1989. Steiner H, McBean GJ, Kohler C, Roberts PJ, Schwarcz R. Ibotenate Induced neuronal degeneration in immature rat brain. Brain Research 307:117-124, 1984. Dr. Steiner is rated as an Advanced provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Bronchiectasis, Obstructive Sleep Apnea, Lung Metastases, and Interstitial Lung Disease.

Dr. Buescher is a pulmonary critical care physician. He has been deeply involved in clinical teaching of both medical students, interns, residents and fellows throughout his career. He is the director of the Medical/Surgical Critical Care Units at MedStar Union Memorial Hospital as well as MedStar Good Samaritan Hospital. He is president of a large community private practice pulmonary and critical group (Pulmonary and Critical Care Associates of Baltimore) He serves at Hopkins on the part-time clinical faculty. Research Summary Dr. Buescher is involved in multiple clinical research projects. Dr. Buescher is rated as an Advanced provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Sarcoidosis, Neurosarcoidosis, Lung Metastases, Endoscopy, and Gastrostomy.

Amal Hassan Ahmed Awadalla, M.D., practices internal medicine at Johns Hopkins Community Physicians East Baltimore Medical Center. She received her medical degree from Faculty of Medicine University of Khartoum, and completed her residency at Queens Hospital Center. Dr. Awadalla is rated as an Advanced provider by MediFind in the treatment of Neurosarcoidosis. Her top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Neurosarcoidosis, and Sarcoidosis.

Neurologist Scott Newsome specializes in the care of patients with neuroimmunological and neuroinflammatory disorders of the central nervous system. He works within the Division of Neuroimmunology and Neurological Infections at The Johns Hopkins Hospital, and has special interest in evaluating and treating patients with multiple sclerosis, transverse myelitis, neuromyelitis optica and stiff person syndrome. After completing fellowship training, Dr. Newsome joined the Johns Hopkins Multiple Sclerosis and Transverse Myelitis Centers, and he is the director of the Johns Hopkins Neurosciences Consultation and Infusion Center and the Stiff Person Syndrome Center. He is also director of the Johns Hopkins Neuroimmunology and Neurological Infectious Disease Fellowship Program and co-director of the Multiple Sclerosis Experimental Therapeutics Program. Dr. Newsome received his medical degree from the New York College of Osteopathic Medicine, with honors. During his neurology residency, he was awarded the Golden Apple Outstanding Resident Teaching Award, and later was chosen to be chief resident. He subsequently completed a fellowship in neuroimmunology at The Johns Hopkins Hospital with the support of a Sylvia Lawry Physician Fellowship Award from the National Multiple Sclerosis Society. Identifying and testing novel therapies and therapeutic strategies for multiple sclerosis and other neuroimmunological disorders is Dr. Newsome’s main research focus. Other research endeavors include validating the use of new quantitative clinical outcome measures and imaging techniques in multiple sclerosis and identifying risk factors of disease onset and severity, response to treatment and long-term outcomes in neuroimmunological disorders. An adviser for the National Multiple Sclerosis Society and a member of the Miller-Coulson Academy of Clinical Excellence, Dr. Newsome has also served as president of the Consortium of Multiple Sclerosis Centers. Dr. Newsome is rated as an Advanced provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Stiff Person Syndrome, Multiple Sclerosis (MS), Transverse Myelitis, and Relapsing Multiple Sclerosis (RMS).

Dr. McCormack is a pulmonary, critical care physician and Associate Director of the Pulmonary & Critical Care Medicine Division. She is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. She has expertise in pulmonary physiology. She serves as the Medical Director of the Johns Hopkins University Pulmonary Function Laboratory and as the Chair of the American Thoracic Society Pulmonary Function Test Committee. She earned her M.D. from Jefferson Medical College of Thomas Jefferson University and her M.H.S. from the Bloomberg School of Public Health. She completed her residency at Thomas Jefferson University Hospital and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. She was the recipient of the Frederick L. Brancati Excellence in Mentoring Award. She plays an active role in mentoring fellows and junior faculty in the Pulmonary & Critical Care Medicine Division. Dr. Mccormack is rated as an Advanced provider by MediFind in the treatment of Neurosarcoidosis. Her top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Asthma, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant.

David Moller is a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Moller is rated as a Distinguished provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Sarcoidosis, Neurosarcoidosis, Interstitial Lung Disease, and Acute Interstitial Pneumonia.

George Reeder is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Salisbury, Maryland. Dr. Reeder is rated as a Distinguished provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Acute Interstitial Pneumonia, and Interstitial Lung Disease. Dr. Reeder is currently accepting new patients.

Nevins Todd is an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Todd is rated as an Advanced provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Pneumonia, Sarcoidosis, and Endoscopy.

Tania Hudson is an Intensive Care Medicine provider in Salisbury, Maryland. Dr. Hudson is rated as an Advanced provider by MediFind in the treatment of Neurosarcoidosis. Her top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Neurosarcoidosis, Gastrostomy, and Hip Replacement.

Peter Calabresi is a Neurologist in Baltimore, Maryland. Dr. Calabresi is rated as an Advanced provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Multiple Sclerosis (MS), Optic Neuritis, Relapsing Multiple Sclerosis (RMS), and CACH Syndrome.

Jason Birnbaum is a Pulmonary Medicine provider in Bel Air, Maryland. Dr. Birnbaum is rated as an Advanced provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Asthma, Gastrostomy, and Endoscopy.

Robert Chasse is an Intensive Care Medicine provider in Salisbury, Maryland. Dr. Chasse is rated as an Advanced provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Acute Interstitial Pneumonia, Lung Metastases, Neurosarcoidosis, Gastrostomy, and Advanced Bronchoscopy.

Surjit Julka is an Intensive Care Medicine provider in Owings Mills, Maryland. Dr. Julka is rated as an Advanced provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Asthma in Children, Chronic Obstructive Pulmonary Disease (COPD), Asthma, and Lung Metastases.